U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07177417) titled 'Characterizing the Human Airway Immune Response to FluMist Vaccination' on Sept. 09.
Brief Summary: The goal of this clinical trial is to measure the immune response in the blood, nose, and lungs after participants receive either the FDA-approved inactivated influenza vaccine or the FDA-approved intranasal FluMist vaccine. The study will evaluate immune responses in groups of healthy, non-pregnant, volunteers between the ages of 18 and 40. The main purpose of the study is to measure the change in influenza vaccine-specific antibodies in the lower lungs and nose between vaccination and 14 days after participants receive the vaccine....